Company Announcements

Publication of Q3 2024 Factsheet

Source: RNS
RNS Number : 7697H
Onward Opportunities Limited
11 October 2024
 

 

11 October 2024

 

Onward Opportunities Limited

("Onward Opportunities" or the "Company")

 

Publication of Q3 Factsheet

 

Onward Opportunities Limited (AIM: ONWD), the investment company targeting opportunities in smaller companies within the UK, is pleased to announce the publication of the Company's Q3 factsheet for the three months to 30 September 2024, which can be found at the Company's website:

 https://onwardopportunities.co.uk/quarterly-factsheets-commentary/

 

For further information, please contact:

                                    

Onward Opportunities Limited

Andrew Henton, Chairman

 

Dowgate Wealth Limited (Portfolio Manager)

Laurence Hulse, Lead Fund Manager

 

 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk 

 

Apex Administration (Guernsey) Limited (Company Secretary)

Chris Bougourd / Harry Rouillard

 

Tel: +44 (0) 203 5303 150

ool@apexgroup.com

 

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Ben Jeynes / Camilla Hume - Corporate Finance

Michael Johnson / Chris West / Charlie Combe - Sales and ECM

 

Tel: +44 (0)20 7220 0500

Dowgate Capital Limited (Joint Broker)

Russell Cook / Nicholas Chambers

 

Tel: +44 (0)12 9351 7744

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCFFEFMSELSESS